PSTV
Price
$0.79
Change
-$0.05 (-5.95%)
Updated
Apr 25, 02:44 PM (EDT)
Capitalization
14.33M
ZYME
Price
$12.41
Change
-$0.11 (-0.88%)
Updated
Apr 25, 03:59 PM (EDT)
Capitalization
871.1M
Ad is loading...

PSTV vs ZYME

Header iconPSTV vs ZYME Comparison
Open Charts PSTV vs ZYMEBanner chart's image
Plus Therapeutics
Price$0.79
Change-$0.05 (-5.95%)
Volume$1K
Capitalization14.33M
Zymeworks
Price$12.41
Change-$0.11 (-0.88%)
Volume$300
Capitalization871.1M
PSTV vs ZYME Comparison Chart
Loading...
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PSTV vs. ZYME commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSTV is a Hold and ZYME is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PSTV: $0.84 vs. ZYME: $12.52)
Brand notoriety: PSTV and ZYME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PSTV: 10% vs. ZYME: 48%
Market capitalization -- PSTV: $14.33M vs. ZYME: $871.1M
PSTV [@Biotechnology] is valued at $14.33M. ZYME’s [@Biotechnology] market capitalization is $871.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PSTV’s FA Score shows that 0 FA rating(s) are green whileZYME’s FA Score has 0 green FA rating(s).

  • PSTV’s FA Score: 0 green, 5 red.
  • ZYME’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYME is a better buy in the long-term than PSTV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSTV’s TA Score shows that 4 TA indicator(s) are bullish while ZYME’s TA Score has 6 bullish TA indicator(s).

  • PSTV’s TA Score: 4 bullish, 4 bearish.
  • ZYME’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ZYME is a better buy in the short-term than PSTV.

Price Growth

PSTV (@Biotechnology) experienced а +27.95% price change this week, while ZYME (@Biotechnology) price change was +8.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

PSTV is expected to report earnings on Mar 31, 2025.

ZYME is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYME($871M) has a higher market cap than PSTV($14.3M). ZYME YTD gains are higher at: -14.481 vs. PSTV (-26.722). PSTV has higher annual earnings (EBITDA): -8.47M vs. ZYME (-108.62M). ZYME has more cash in the bank: 226M vs. PSTV (4.79M). PSTV has less debt than ZYME: PSTV (3.4M) vs ZYME (18.5M). ZYME has higher revenues than PSTV: ZYME (76.3M) vs PSTV (0).
PSTVZYMEPSTV / ZYME
Capitalization14.3M871M2%
EBITDA-8.47M-108.62M8%
Gain YTD-26.722-14.481185%
P/E RatioN/AN/A-
Revenue076.3M-
Total Cash4.79M226M2%
Total Debt3.4M18.5M18%
FUNDAMENTALS RATINGS
PSTV vs ZYME: Fundamental Ratings
PSTV
ZYME
OUTLOOK RATING
1..100
3318
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
8354
P/E GROWTH RATING
1..100
10059
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZYME's Valuation (49) in the Pharmaceuticals Major industry is in the same range as PSTV (51) in the null industry. This means that ZYME’s stock grew similarly to PSTV’s over the last 12 months.

ZYME's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PSTV (100) in the null industry. This means that ZYME’s stock grew similarly to PSTV’s over the last 12 months.

ZYME's SMR Rating (91) in the Pharmaceuticals Major industry is in the same range as PSTV (99) in the null industry. This means that ZYME’s stock grew similarly to PSTV’s over the last 12 months.

ZYME's Price Growth Rating (54) in the Pharmaceuticals Major industry is in the same range as PSTV (83) in the null industry. This means that ZYME’s stock grew similarly to PSTV’s over the last 12 months.

ZYME's P/E Growth Rating (59) in the Pharmaceuticals Major industry is somewhat better than the same rating for PSTV (100) in the null industry. This means that ZYME’s stock grew somewhat faster than PSTV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PSTVZYME
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHAIX10.18N/A
N/A
JHancock Multi-Asset Absolute Return I
REGRX16.40N/A
N/A
Russell Inv Emerging Markets R6
THISX76.90N/A
N/A
T. Rowe Price Health Sciences I
PGJQX16.98N/A
N/A
PGIM Jennison Global Infrastructure R6
AVUGX7.54N/A
N/A
American Century Value R5

PSTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTV has been loosely correlated with OPT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTV jumps, then OPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTV
1D Price
Change %
PSTV100%
-14.32%
OPT - PSTV
35%
Loosely correlated
N/A
DRUG - PSTV
33%
Poorly correlated
-1.99%
PBIGF - PSTV
29%
Poorly correlated
N/A
ZYME - PSTV
28%
Poorly correlated
+0.56%
ARRY - PSTV
27%
Poorly correlated
+5.31%
More